No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.
www.xzyy.cnNo one on the platform currently holds 600211.SS.
No tracked institution reports a position in 600211.SS as of their last filing.
No one on the platform has traded 600211.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.8B | +4.0% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600211.SSTibet Rhodiola Pharmaceutical Holding Co. Class A | $36.20 | +0.25% | $11.7B | — |
| 000403.SZPacific Shuanglin Bio-pharmacy Co., Ltd. | $10.03 | +0.30% | $9.5B | — |
| 002020.SZZhejiang Jingxin Pharmaceutical Co., Ltd. | $11.42 | -0.35% | $9.8B | — |
| 002287.SZTibet Cheezheng Tibetan Medicine Co., Ltd. | $19.10 | -1.29% | $10.9B | — |
| 600216.SSZhejiang Medicine Co., Ltd. | $12.48 | -0.08% | $12.0B | — |
| 600285.SSHenan Lingrui Pharmaceutical Co., Ltd. | $19.25 | -0.10% | $10.9B | — |
| 600420.SSShanghai Shyndec Pharmaceutical Co., Ltd. | $8.23 | -0.24% | $11.0B | — |
Source: Financial Modeling Prep · peers by sector/industry